GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: OMP-313M32
                                 Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Etigilimab (OMP-313M32) is an anti-TIGIT monoclonal antibody [1]. Blocking the TIGIT/PVR interaction is proposed to promote anti-tumour immunity. This mechanism is proposed to be used in conjunction with anti-PD/1/PD-L1 immuno-oncology therapeutics, to further enhance the anti-tumour immune response.
                                    
                                 | 
| Classification  | |
| Compound class | Antibody | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 10742 | etigilimab | 
| Synonyms  | 
| OMP-313M32 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 803 | 
| Other databases | |
| GtoPdb PubChem SID | 518520611 | 
| Search PubMed clinical trials | etigilimab | 
| Search PubMed titles | etigilimab | 
| Search PubMed titles/abstracts | etigilimab |